- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Sarnoff To Identify and Pursue Applications, Markets, and Licensees Under Five-Year Agreement
Sarnoff Corporation of Princeton, New Jersey, today announced a five-year strategic agreement with ExxonMobil Research and Engineering Company (EMRE) of Fairfax, Virginia, under which commercialization opportunities for EMRE's groundbreaking portfolio of mesoporous materials will be identified in markets outside of the petrochemical industry.
The materials, which include novel high surface area silicas, are among the first nanomaterials ever created and have been commercialized by ExxonMobil for its own use. Under the agreement Sarnoff will work with EMRE to position these materials in other markets, such as electronics and optics, where their unique properties offer significant advantages over current materials.
Sarnoff is also pursuing select third party participation in developing electronic systems and devices based on these nanomaterials. Opportunities in other applications will also be considered.
According to John Riganati, vice president of technology strategy for Sarnoff, both technical and business factors played a role in determining the initial areas of development.
"Sarnoff and ExxonMobil considered eight possible startup projects and chose three for initial exploration," said Riganati. "The selection was based on both the technical advantages of the materials and their business potential in each area."
EMRE's mesoporous materials include various types of molecular structures that can be tailored to the needs of a specific application. Sarnoff (www.sarnoff.com), formerly RCA Labs, is an international innovation services and product development company focusing on advanced technologies and applications in video, microelectronics, imagers, and related fields.
EMRE is the downstream research and engineering arm of ExxonMobil Corporation, a leading global oil, natural gas, and petrochemicals company whose subsidiaries have operations in approximately 200 countries and territories. More information regarding ExxonMobil and technologies it licenses can be found here.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
Researchers develop new way to manufacture nanofibers May 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015